Anti Citrullinated Protein Antibodies and Mechanism of Action of Common Disease Modifying Drugs - Insights in Pathomechanisms of Autoimmunity

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|29|4526-4536

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.29, 2012-10, pp. : 4526-4536

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 11, Iss. 5, 2012-08 ,pp. : 610-623

Bentham Science Publishers

Access to resources Recommend Favorite

Relatives Without Rheumatoid Arthritis Show Reactivity to Anti–Citrullinated Protein/Peptide Antibodies That Are Associated With Arthritis‐Related Traits: Studies of the Etiology of Rheumatoid Arthritis

Arthritis & Rheumatism, Vol. 65, Iss. 8, 2013-08 ,pp. : 1995-2004

John Wiley & Sons Inc

Access to resources Recommend Favorite

An Update on Disease Modifying Antirheumatic Drugs

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 13, Iss. 4, 2014-08 ,pp. : 249-261

Bentham Science Publishers

Access to resources Recommend Favorite

The Mechanisms of Action of Disease-Modifying Antirheumatic Drugs: A Review with Emphasis on Macrophage Signal Transduction and the Induction of Proinflammatory Cytokines

By Bondeson J.

General Pharmacology, Vol. 29, Iss. 2, 1997-08 ,pp. : 127-150

Elsevier

Access to resources Recommend Favorite

Mechanisms of Action of Non-Steroidal Anti-Inflammatory Drugs for the Prevention of Alzheimer's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 2, 2010-04 ,pp. : 140-148

Bentham Science Publishers

Access to resources Recommend Favorite